‘Pharma Bro’ Martin Shkreli is in trouble with regulators again, this time for influencing biopharma stocks
发生了什么
The controversial investor has been weighing in on biopharma stocks even though he’s banned from doing so.
摘要按规则整理自下方来源原文
The controversial investor has been weighing in on biopharma stocks even though he’s banned from doing so.
摘要按规则整理自下方来源原文